Spots Global Cancer Trial Database for IMPACT Trial: Intervention to iMProve AdherenCe Equitably
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: IMPACT Trial: Intervention to iMProve AdherenCe Equitably
Official Title: IMPACT Trial: Intervention to iMProve AdherenCe Equitably
Study ID: NCT05496829
Conditions
Study Description
Brief Summary: To determine the efficacy of a multicomponent adherence intervention among participants with early-stage breast cancer on endocrine therapy and at least one oral cardiovascular disease (CVD) medication on adherence to endocrine therapy and to CVD medication at 24 weeks assessed by self-report using the Domains of Subjective Extent (DOSE)-Nonadherence questionnaire and also by pharmacy fill data assessed in the electronic health record (EHR).
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Columbia University Medical Center, New York, New York, United States
Contact Details
Name: Dawn Hershman, MD
Affiliation: Columbia University
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
